Glazer Capital, LLC 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-10 2:34 pm Purchase | 2025-09-02 | 13G | scPharmaceuticals Inc. SCPH | Glazer Capital, LLC | 2,474,820 4.640% | 2,474,820 (New Position) | Filing |
| 2025-09-09 4:31 pm Purchase | 2025-09-02 | 13G | scPharmaceuticals Inc. SCPH | Glazer Capital, LLC | 2,474,820 4.640% | 2,474,820 (New Position) | Filing |